Chroma Medicine
BOSTON, MA · Founded 2020 · CIK 0001967386 · Biotech · Acquired
Targeted in vivo genetic medicine delivery system for durable therapeutic effect
chromamedicine.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $135M
- 1 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $135,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2800 | VYNE Therapeutics Inc. | — | $139M |
| 2801 | Silverback Therapeutics | — | $139M |
| 2802 | VANQUA BIO, INC. | — | $136M |
| 2803 | Chroma Medicine | — | $135M |
| 2804 | ANSA BIOTECHNOLOGIES, INC. | — | $123M |
| 2805 | Frontier Medicines | — | $122M |
| 2806 | Praxis Precision Medicine | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- KEVIN BITTERMANDirector
- THOMAS CAHILLDirector
- BIHUA CHENDirector
- GEORGE GOLUMBESKIDirector
- BRETT KAPLANExecutive Officer
- MICHAEL KELLYDirector
- JEFF MARRAZZODirector
- VIC MYERExecutive Officer
- PAOLA POZZIDirector
- CATHERINE STEHMAN-BREENDirector · Executive Officer
Patents
- Compositions And Methods For Epigenetic Regulation Of Gene Expressionapplication
- Gene Silencingapplication
- Compositions And Methods For Epigenetic Regulation Of Ciita Expressionapplication
- Compositions And Methods For Epigenetic Regulation Of PCSK9 Expressionapplication
- Gene Silencingapplication
- Compositions And Methods For Epigenetic Regulation Of ZNF410 Expressionapplication
- Compositions And Methods For Epigenetic Regulation Of Hbv Gene Expressionapplication
- Compositions And Methods For Epigenetic Editingapplication
- Compositions And Methods For Epigenetic Regulation Of Htt Expressionapplication
- Compositions And Methods For Epigenetic Regulation Of ZNF410 Expressionapplication
- Compositions And Methods For Epigenetic Editingapplication
- Compositions And Methods For Epigenetic Regulation Of Transforming Growth Factor Beta Receptor 2 (TGFBR2) Expressionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.